Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

Strategies to Treat Osteoporosis Following a Fragility Fracture (OPTIMUS)

This study is ongoing, but not recruiting participants.
Sponsor:
Collaborators:
Merck Sharp & Dohme Corp.
Procter and Gamble
Sanofi
Novartis
Amgen
Eli Lilly and Company
Servier
Warner Chilcott
Information provided by (Responsible Party):
Gilles Boire, Université de Sherbrooke
ClinicalTrials.gov Identifier:
NCT00512499
First received: August 3, 2007
Last updated: October 30, 2013
Last verified: October 2013
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is ongoing, but not recruiting participants.
  Estimated Study Completion Date: June 2016
  Primary Completion Date: July 2013 (Final data collection date for primary outcome measure)